Monopar to Present New Long-Term Neurological Efficacy and Safety Data for ALXN1840 in Wilson Disease at the 150th American Neurological Association Annual Meeting

globenewswire

Monopar to Present New Long-Term Neurological Efficacy and Safety Data for ALXN1840 in Wilson Disease at the 150th American Neurological Association Annual Meeting – NEWSnet – News… as it used to be

More Press Releases

June 22, 2026

As Xylazine Addiction Increases in Idaho Women, Renaissance Refuge Offers Hope

June 22, 2026

What the Medicaid Cuts in the One Big Beautiful Bill Mean for Your Loved One in a Nursing Home

June 22, 2026

How to Start a Beverage Company: Fast Moving Consumer Goods Launches Weekly Webinar for Founders, Investors, and CPG Professionals

June 22, 2026

Monopar to Present New Long-Term Neurological Efficacy and Safety Data for ALXN1840 in Wilson Disease at the 150th American Neurological Association Annual Meeting

As Xylazine Addiction Increases in Idaho Women, Renaissance Refuge Offers Hope

What the Medicaid Cuts in the One Big Beautiful Bill Mean for Your Loved One in a Nursing Home

How to Start a Beverage Company: Fast Moving Consumer Goods Launches Weekly Webinar for Founders, Investors, and CPG Professionals

New Veterans’ Benefits Legislation Moves Forward – Mesothelioma Veterans Stand to Gain